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A C C E P T E D M A N U S C R I P T
Further discussion of a preliminary study of sleep quality in functional neurological disorders: A reply to Professor Kawada. We would like to thank Prof. Kawada for his interest in our manuscript (1), which describes a preliminary investigation of sleep quality in people with functional neurological disorders (FND).
Below we respond to Prof. K 1. Prof. Kawada writes, the authors did not explain the opposite direction in beta values of anxiety and depression by a regression analysis While our paper focuses on the relationship between sleep and FND-related functional impairment, Prof. Kawada is correct in noticing that, in step 4 of the regression analysis (in Table 2 of Graham & Kyle, 2017(1)), anxiety becomes negatively associated with FND-related functional impairment when depression is entered into the model. We attribute this effect to shared variance between anxiety and depression, with depression being a strong predictor of FND-related functional impairment. Variance inflation factors (2.03 and 2.39) and tolerance statistics (0.49 and 0.42) suggested that it would be acceptable concurrently to include both depression and anxiety. However, we agree that a principal components analysis of depression and anxiety items could be used to derive an alternative factorial solution that could subsequently be entered into the regression model. 2. Prof. Kawada remarks that, Percentages of medications in anti-depressants and benzodiazepines were 52.7% and 9.3%, and the difference of prescription rate would partly contribute to the result W -vary with FND-related functional impairment. In addition, it may also act as a proxy for severity of sleep disturbance and/or distress, which was captured by our questionnaires. Consistent with our aims, we focused on self-reported sleep disturbance in this first study but we concur that future studies, using appropriate designs, should investigate a range of potential intermediate pathways linking sleep to functional impairment and other outcomes in FND.
A
The authors handled relatively young patients with having FND-related functional impairment . In contrast, the age range of our online sample (M = 40.42 years, SD = 10.83) was commensurate with those of previous large FND cohort studies (M = 39.1; M = 37.2, SD =13.7) (2, 3) and our clinical sample (M = 37.85, SD = 15.96). In addition, FND have variable age of onset, are not generally progressive, and can spontaneously remit. Therefore, age or years with FND are less likely to be indicators of symptom severity or symptom-related functional impairment than in progressive neurological conditions. 4. Finally, Prof. Kawada writes In addition, difference of clinical symptoms and stages in several neurological disorders would also be related to the results. As the number of samples
